The relevance of RRAS2 overexpression has been proven here by generating an RRAS2 knockdown variant of the CLL human cell line MEC-1, which shows impaired capacity to proliferate in vitro and to form tumors in vivo. This evidence concerns the gene RRAS2 and B-cell chronic lymphocytic leukemia.